Evidence for the involvements of AKAPs in the PKC-ERK1/2 pathway was presented by Su et al. 16, who found that SSeCKS/Gravin/AKAP12 inhibits cancer invasiveness and chemotaxis by suppression of the PKC-Raf/MEK/ERK1/2 pathway. Here, MAPK3 is linked to cancer.